In the current study, our results could not reveal if increased liver inflammation in the Osr1+/- mice is a cause or a consequence of the steatosis, thus it is unclear if the worsened steatosis or the enhanced hepatic inflammation is the driving force for NAFLD progression. The gene discussed is OSR1; the disease is steatosis.